Clinical Trial Update: Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating whether Avelumab or Hydroxychloroquine, with or without Palbociclib, can eliminate dormant breast cancer. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avelumab (avelumab)
• Hydroxychloroquine (hydroxychloroquine)
• Palbociclib (palbociclib)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING